Editorial Board

Eric H. Baehrecke, PhD, University of Massachusetts Chan Medical School, United States of America
Mariano Barbacid, PhD, Spanish National Cancer Research Center (CNIO), Spain
C. Elizabeth Caldon, PhD, LLB, UNSW Sydney, Australia
Arul M. Chinnaiyan, MD, PhD, University of Michigan, United States of America
Ruggero De Maria, MD, Catholic University of Sacred Heart, Italy
Dechao Feng, PhD, Sichuan University, China
Michael Hahne, PhD, Centre National de la Recherche Scientifique, France
Marja Jäättelä, PhD, Danish Cancer Institute, Denmark
Guido Kroemer, MD, PhD, Université Paris Cité, France
Rakesh Kumar, PhD, Himalayan Institute of Medical Sciences, India
Kristiaan J. Lenos, PhD, Amsterdam University Medical Centers, The Netherlands
Alexander Lewis, PhD, Peter MacCallum Cancer Centre, Australia
Seamus J. Martin, PhD, MRIA, MAE, Trinity College Dublin, Ireland
René H. Medema, PhD, The Netherlands Cancer Institute, The Netherlands
Gerry Melino, MD, PhD, Dr Sci, University Tor Vergata, Italy
Cristina Muñoz-Pinedo, PhD, Institut d’Investigació Biomèdica de Bellvitge, Spain
Irene O.L. Ng, MBBS, MD, PhD, FHKAM(Pathology), FHKCPath, FRCPath, The University of Hong Kong, China
Salvatore Papa, PhD, University of Leeds, United Kingdom
Jonathan R. Pollack, MD, PhD, Stanford University, United States of America
Arturo Sala, PhD, Brunel University London, United Kingdom
Michele Sallese, PhD, G. d’ Annunzio University of Chieti-Pescara, Italy
Giorgio Stassi, MD, University of Palermo, Italy
Stephen Tait, DPhil, Cancer Research UK Scotland Institute, United Kingdom
François M. Vallette, PhD, Nantes Université. France
Keith T. Wilson, MD, Vanderbilt University Medical Center, United States of America
Jun Yu, MD, PhD, The Chinese University of Hong Kong, China